NovaSterilis

06/01/2026

Reusable devices with long lumens present persistent challenges due to organic buildup and biofilm formation.

This white paper examines how sterilization can overcome these hard water, serum, and lumen pe*******on challenges while achieving effective spore inactivation.

Read the full white paper: https://bit.ly/46JHuSW

05/28/2026

Our Medical Device Compatibility Guide explores sterilization compatibility across combination, implantable, topical, and electronic medical devices.

The guide outlines material considerations and device category suitability for scCO2 processing.

Download your copy here: https://bit.ly/3S6SKnf

05/27/2026

Peptides and GLP-1 analogs require early evaluation of compatibility.

provides low-temperature processing for many types of sensitive biologics.

Explore compatibility-first sterilization strategies and testing approaches:

Explore the challenges of peptides, GLP-1s, and complex biologics sterilization, and new approaches for sensitive therapeutic development.

05/26/2026

This research from the Mayo Clinic evaluates the impact of different techniques on the mechanical properties of xenograft heart valves.

Results found that only achieved total sterility without matrix cross-linking or structural damage, preserving collagen integrity and cusp tensile properties.

Read the full study: https://bit.ly/4och58L

05/25/2026

This Memorial Day, we honor and remember the brave individuals who gave their lives in service to our country. 🇺🇸

05/22/2026

This case study sought to quantify the differences in cost between contract e-beam sterilization services vs. in-house scCO2 sterilization equipment. .

The findings revealed that in-house sterilization reduced quarterly costs by over 30% in applications.

Dive into the detailed cost and time comparisons: https://bit.ly/4oj7nkj

05/20/2026

This video shows an empty vessel going through the typical process.

We can observe distinct visual signatures that occur during the pressurization, dwell, and depressurization stages of the process.

NovaSterilis can leverage this video recording capability to provide insights during the compatibility testing process with new materials.

05/18/2026

is a low-temperature, minimally reactive, non-toxic terminal modality.

It is compatible with synthetic and natural materials across dry, hydrated, liquid, and gel-based systems, including products submerged in buffer, as well as thin and viscous hydrogel formulations.

Beyond sterilization, is also used for decellularization, cleaning, and impregnation of bioactives.

See our FAQ page for commonly asked questions about the process and its applications: https://bit.ly/4dHL9X2

05/14/2026

Real-time visualization inside the chamber allows us to have direct observation of material responses.

The NovaGenesis VP-1000’s video capture supports deeper evaluation during processing.

Explore our videos to examine dynamic interactions under process conditions: https://bit.ly/4qZsI4H

05/13/2026

In this study, with low-level peracetic acid was evaluated for amino acid reactivity and EGF integrity.

Oxidative modifications were limited, with reduced reactivity under dry or lyophilized conditions.

Read more about protein-level impacts, residue-specific oxidation, and post-sterilization bioactivity:

Aseptic processing and terminal sterilization become increasingly challenging as medical devices become more complex and include active biologics. Ter…